AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 11, 2023
People who took a cheap diabetes drug after testing positive for COVID-19 had a 40 percent lower risk of getting long COVID, a US-based study said Friday.
JAMA Internal Medicine
JUNE 11, 2023
This meta-analysis assesses the efficacy and safety of oseltamivir in preventing hospitalization among influenza-infected adult and adolescent outpatients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 11, 2023
The Central Drugs Standard Control Organisation (CDSCO) has declared a batch of Typbar, the typhoid polysaccharide vaccine from Bharat Biotech International Ltd as not of standard quality (NSQ).
Cloudbyz
JUNE 11, 2023
Introduction In an increasingly digital age, healthcare is following suit by integrating digital technologies into its practices. This transformation has permeated the domain of clinical trials, which is now embracing the concept of decentralized clinical trials (DCTs). This paper delves deep into the universe of DCTs, their distinctiveness from conventional trials, their inherent benefits, existing hurdles, and measures to bolster their adoption.
pharmaphorum
JUNE 11, 2023
Novartis builds hefty IgAN pipeline with $3.5bn Chinook buy Phil.
The Pharma Data
JUNE 11, 2023
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) today announced that patients treated with BI 456906 achieved up to 14.9% weight loss after 46 weeks, using the planned maintenance dose. The phase II clinical trial evaluating the effect of different doses of the novel glucagon/GLP-1 receptor dual agonist BI 456906 in people living with obesity or overweig
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
The Pharma Data
JUNE 11, 2023
New clinical handbook launched to support quality abortion care The World Health Organization (WHO) today released a new handbook for health workers to help them deliver quality abortion services for women and girls. The publication provides detailed clinical advice to support the implementation of WHO’s consolidated guidance on abortion care, published in 2022.
pharmaphorum
JUNE 11, 2023
Illumina CEO resigns amid investor pressure Phil.
FDA Law Blog
JUNE 11, 2023
By Mark A. Tobolowsky & David B. Clissold — In May 2023, CDER and CBER published a draft guidance titled “Pediatric Drug Development: Regulatory Considerations – Complying with the Pediatric Research Equity Act [“PREA”] and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act [“BPCA”]” (the “Draft Guidance”). This Draft Guidance, in part, replaces a 2005 guidance titled “How to Comply with the Pediatric Research Equity Act.
Expert insights. Personalized for you.
165 
Let's personalize your content